Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.
The UL97 phosphotransferase coding sequences of clinical cytomegalovirus (CMV) isolates, 10 resistant and 11 sensitive to ganciclovir, were compared to define mutations associated with drug resistance. In each ganciclovir-resistant isolate, a mutation was found that resulted in an amino acid substitution at codon 460 (4 isolates), codon 594 (2 isolates), or codon 595 (4 isolates). No sensitive isolate carried any of these mutations. Marker transfer studies showed that each mutation was capable of conferring ganciclovir resistance to the laboratory CMV strain AD169. Rapid diagnostic tests based on DNA amplification and restriction enzyme analysis were developed for these mutations. Specific mutant DNAs were detected when they constituted at least 10% of the population in the specimen. Several mutations in UL97 appear to be common markers for ganciclovir resistance, and their detection may be a rapid alternative to conventional cell culture susceptibility testing.
Chou
S
S
Medical Service, VA Medical Center, Portland, OR 97201.
Erice
A
A
Jordan
M C
MC
Vercellotti
G M
GM
Michels
K R
KR
Talarico
C L
CL
Stanat
S C
SC
Biron
K K
KK
D000595:Amino Acid Sequence; D001483:Base Sequence; D003062:Codon; D003587:Cytomegalovirus / Q000187:drug effects / Q000235:genetics*; D004351:Drug Resistance / Q000235:genetics; D015774:Ganciclovir / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation; D010770:Phosphotransferases / Q000235:genetics*
D003062:Codon; D010770:Phosphotransferases; D015774:Ganciclovir